logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Collegium Pharmaceutical, Inc. drugs

    FiltersReset Filters
    3 results

    • nucynta

      (tapentadol hydrochloride)
      Collegium Pharmaceutical, Inc.
      Usage: NUCYNTA ER (tapentadol) is indicated for managing severe, persistent pain in adults requiring long-term opioid treatment when alternatives are inadequate. It is also indicated for severe neuropathic pain associated with diabetic peripheral neuropathy in adults under similar circumstances. It is not intended for as-needed use.

    • nucynta

      (tapentadol hydrochloride)
      Collegium Pharmaceutical, Inc.
      Usage: NUCYNTA (tapentadol) is indicated for managing acute pain in adults and pediatric patients (aged 6 years and older, weighing at least 40 kg) when alternative treatments are inadequate. It should be reserved for patients where non-opioid options have failed or are not tolerated, and used cautiously due to addiction risks.

    • xtampza

      (OXYCODONE)
      Collegium Pharmaceutical, Inc.
      Usage: XTAMPZA ER is indicated for the management of severe, persistent pain requiring long-term opioid treatment when alternative options are inadequate. It is not recommended for as-needed use and should be reserved for patients at risk of addiction or misuse when other treatments fail.